Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WDR5 | P61964 | 11/20 | 0.46 |
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 0.43 |
| ▸ | TAOK3 | Q9H2K8 | 1/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.42 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.42 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.42 |
| ▸ | DHODH | Q02127 | 1/20 | 0.42 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.40 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2819212 | 1.00 | WDR5 (0.46) | WDR5TAOK1TAOK3PDE4APDE4B | |
| SCHEMBL13190100 | 0.93 | WDR5 (0.46) | WDR5PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL2820770 | 0.92 | TAOK1 (0.45) | WDR5TAOK1TAOK3PDE4APDE4B | |
| SCHEMBL2820769 | 0.92 | TAOK1 (0.45) | WDR5TAOK1TAOK3PDE4APDE4B | |
| SCHEMBL2819996 | 0.88 | PDE10A (0.51) | WDR5PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL2820001 | 0.88 | PDE10A (0.51) | WDR5PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL13190010 | 0.86 | PDE10A (0.43) | WDR5TAOK1TAOK3PDE4APDE4B | |
| SCHEMBL2821726 | 0.81 | PDE10A (0.51) | WDR5PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL2821723 | 0.81 | PDE10A (0.51) | WDR5PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL485043 | 0.81 | MEN1 (0.51) | WDR5PDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130231327-A1 | Substituted Spiro-Amide Compounds | GRUENENTHAL GMBH (DE) | 2013-09-05 | — | — | US | disclosed |
| US-8455475-B2 | Substituted spiro-amide compounds | GRUENENTHAL GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | GRUENENTHAL GMBH (DE) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130231327-A1 | Substituted Spiro-Amide Compounds | BDKRB1, BDKRB2, REN | WDR5 1762/4885TAOK1 1352/4885TAOK3 1405/4885 |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | BDKRB1, BDKRB2, REN | WDR5 1762/4885TAOK1 1352/4885TAOK3 1405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.